Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
TriLink BioTechnologies
TriLink BioTechnologies
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Analysis
The analytics advancements driving mRNA breakthroughs
mRNA therapeutics are attracting attention because they can be manufactured rapidly to treat previously undruggable diseases
Ingredients
TriLink offers new GMP-grade material for mRNA manufacturing
N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allows researchers to accelerate their drug discovery and development
Design & Build
TriLink to open GMP facility aimed at early phase therapeutic manufacturing
Plant will be fully operational by July
Design & Build
TriLink BioTechnologies to work with American Cleanroom Systems to build cGMP facility
Will contain nine labs and is scheduled to be completed in the first quarter of 2014
Subscribe now